STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

Birkenfeld, March 19, 2025

STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) is today announcing a postponement in the publication date for its 2024 Annual Report. Publication is now scheduled for April 29, 2025. This postponement is to be viewed in connection with the increased time and coordination required due to the change of external auditor (initial audit), as well as with capacity bottlenecks, some of which sickness-related, in the finance department.

Prior to publication of its Annual Report, STRATEC plans to publish its preliminary results for the 2024 financial year together with its guidance for 2025. The exact date for this publication will be announced in advance. Based on current information, STRATEC expects that the targets formulated for the 2024 financial year, namely consolidated sales to remain stable or decline slightly (on a constant-currency basis) and an adjusted EBIT margin of around 10.0% to 12.0%, have been met.

Given mandatory convocation deadlines, the new publication date for the 2024 Annual Report will also make it necessary to postpone the Annual General Meeting scheduled to take place on May 23, 2025. The 2025 Annual General Meeting will now be held on June 17, 2025.

ABOUT STRATEC
STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and life sciences. Furthermore, the company offers complex consumables for diagnostic and medical applications. For its analyzer systems and consumables, STRATEC covers the entire value chain – from development to design and production through to quality assurance.

The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of patented technologies.

Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange.

FURTHER INFORMATION IS AVAILABLE FROM:
STRATEC SE
Jan Keppeler, CFA | Investor Relations, Sustainability & Corporate Communications
Tel: +49 7082 7916-6515
ir@stratec.com
www.stratec.com